Patent: 8,754,045
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 8,754,045
Title: | Enzymatic debridement therapy for abnormal cell proliferation |
Abstract: | Compositions and methods are provided to destroy internal cancerous lesions selectively by the administration of a combination of a debridement protease enzyme and a denaturant of cell structural proteins and or cell adhesion proteins. |
Inventor(s): | Livingston; James A. (Macon, GA) |
Assignee: | |
Application Number: | 11/803,304 |
Patent Claims: | see list of patent claims |
Details for Patent 8,754,045
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Smith & Nephew, Inc. | SANTYL | collagenase | Ointment | 101995 | 06/04/1965 | ⤷ Try a Trial | 2026-05-12 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |